141 – 150 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study
(
- Contribution to journal › Article
-
Mark
Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of primary small and medium vessel vasculitis
(
- Contribution to journal › Article
-
Mark
The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders
(
- Contribution to journal › Article
-
Mark
Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis
(
- Contribution to journal › Article
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
(
- Contribution to journal › Article
-
Mark
A large multicentre analysis of CTGF - 2945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
(
- Contribution to journal › Article